Potential Link between T102C Polymorphism in the Serotonin Receptors (5-HT2A) Gene and Treatment Response of Risperidone on Schizophrenia

Saidah Syamsuddin; Andi Fatimah; Faisal Idrus; Sonny T. Lisal

doi:10.3889/oamjms.2021.6343

Authors

Saidah Syamsuddin Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia https://orcid.org/0000-0002-4331-1680
Andi Fatimah Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia https://orcid.org/0000-0003-4308-4438
Faisal Idrus Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Sonny T. Lisal Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.6343

Keywords:

Schizophrenia, Gene polymorphism, Serotonin receptors gene, 5HT2A, T102C, Risperidone

Abstract

BACKGROUND: Schizophrenia affects 1% of population and its molecular etiology remains enigmatic despite enormous study. Approximately one-third of patients failed to respond with treatment. The 5-HT2A receptor appears to be one of important site of action of atypical antipsychotic drugs. It also has been suggested that the T102C gene polymorphism alters promoter activity and expression of 5-HT2A receptors and might be responsible for the associations with the efficacy of typical antipsychotics.

AIM: In this study, we aimed to evaluate the potential link between T102C polymorphism in the Serotonin Receptors (5-HT2A) and their response to risperidone.

METHODS: We studied 100 schizophrenia patients and 100 healthy volunteers as a comparison of 5-HT2A receptors gene polymorphism distribution, which were all Indonesian. The peripheral blood samples were obtained from all participants. The patients assessed by Positive and Negative Scale (PANSS) and Clinical Global Impression Scale (CGI) when admitted to the hospital. Clinical improvements then assessed 5 times in 4 weeks (when transferred to sub-acute ward, at the 1st, the 2nd, the 3rd, and the 4th week). To analyze the T102C polymorphism of 5-HT2A receptor gene, we used an allele specific polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP) method.

RESULTS: In this study, there were three various polymorphisms of T102C in the serotonin receptor (5-HT2A) gene: T/T, C/C, and T/C. The patients who had homozygous for T/T genotypes were found to give better improvement to risperidone than the patients who were C/C and T/C genotypes (P:0.001). Moreover, the patients with C allele genotype T/C and C/C had minimal response (P:0.001). We found no significant difference distribution of genotypes between schizophrenia patients and healthy volunteers (P:0.498).

CONCLUSION: Our result supported that there was a potential link between T102C polymorphism in the serotonin receptor (5-HT2A) gene and treatment response of risperidone. It suggested the importance of genetic screening such as examination of the Serotonin Receptor 5-HT2A (T102C) gene polymorphism to be performed to optimize therapeutic strategies with antipsychotic.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003;11(6):648-57. https://doi.org/10.1097/00019442-200311000-00009 PMid:14609805 DOI: https://doi.org/10.1097/00019442-200311000-00009

Stahl SM. Stahl’s Essential Psychopharmacology. 4th ed. New York: Cambridge University Press; 2013. p. 129-236.

Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, et al. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry. 1998;3(1):61-6. https://doi.org/10.1038/sj.mp.4000348 PMid:9491814 DOI: https://doi.org/10.1038/sj.mp.4000348

Meltzer HY. The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol. 1995;15 Suppl 1:2S-3S. https://doi.org/10.1097/00004714-199502001-00001 PMid:7730497 DOI: https://doi.org/10.1097/00004714-199502001-00001

Dean B. The cortical serotonin 2A receptor and the pathology of schizophrenia: A likely accomplice. J Neurochem. 2003;85(1):1-13. PMid:12641722 DOI: https://doi.org/10.1046/j.1471-4159.2003.01693.x

Li D, Duan Y, He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun. 2006;340(3):1006-15. https://doi.org/10.1016/j.bbrc.2005.12.101 DOI: https://doi.org/10.1016/j.bbrc.2005.12.101

Hoyer D, Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res. 1986;376(1):97-107. https://doi.org/10.1016/0006-8993(86)90903-0 PMid:2941113 DOI: https://doi.org/10.1016/0006-8993(86)90903-0

Jakab RL, Goldman-Rakic PS. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA. 1998;95(2):735-40. https://doi.org/10.1073/pnas.95.2.735 PMid:9435262 DOI: https://doi.org/10.1073/pnas.95.2.735

Willins DL, Deutch AY, Roth BL. Serotonin5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 1997;27(1):79-82. https://doi.org/10.1002/(sici)1098-2396(199709)27:1<79::aid-syn8>3.0.co;2-a PMid:9268067 DOI: https://doi.org/10.1002/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A

Kim B, Choi EY, Kim CY, Song K, Joo YH. Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting. Hum Psychopharmacol. 2008;23(1):61-7. https://doi.org/10.1002/hup.897 PMid:17924589 DOI: https://doi.org/10.1002/hup.897

Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH. Association of risperidone treatment response with a polymorphism in the 5-HT (2A) receptor gene. Am J Psychiatry. 2002;159(9):1593-5. https://doi.org/10.1176/appi.ajp.159.9.1593 PMid:12202283 DOI: https://doi.org/10.1176/appi.ajp.159.9.1593

Herken H, Emin E, Koray E, Osman S, Sukru A. The relationship between the response to risperidone treatment and 5-HT2A receptor gene (T102C and 1438G/A) polymorphism in schizophrenia. Bull Psychpharmacol. 2003;13:161-6.

Yamanouchi Y, Iwata N, Suzuki T. Effect of DRD2, 5-HT2A and COMT genes on antipsychotic response to risperidone. Pharmacogenomics J. 2003;3(6):356-61. https://doi.org/10.1038/sj.tpj.6500211 PMid:14610521 DOI: https://doi.org/10.1038/sj.tpj.6500211

Manual of Mental Disorder Fifth Edition (DSM-5). USA, American Psychiatrist Association; 2013.

Aneja J. Risperidone response in schizophrenia: A narrative review of pharmaco-genetic research. J Ment Health Clin Psychol. 2018;2:39-47. https://doi.org/10.29245/2578-2959/2018/4.1161 DOI: https://doi.org/10.29245/2578-2959/2018/4.1161

Usall J, Suarez D, Haro JM, SOHO Study Group. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res. 2007;153(3):225-31. https://doi.org/10.1016/j.psychres.2006.09.016 PMid:17681611 DOI: https://doi.org/10.1016/j.psychres.2006.09.016

Leucht S, Engel R. What does the PANSS mean? Schizophr Res 2005;79(2-3):231-8. PMid:15982856 DOI: https://doi.org/10.1016/j.schres.2005.04.008

Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. The clinical global impression-schizophrenia scale: A simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl. 2003;416:16-23. https://doi.org/10.1034/j.1600-0447.107.s416.5.x PMid:12755850 DOI: https://doi.org/10.1034/j.1600-0447.107.s416.5.x